Key Points
- CME Group insider Julie Winkler sold 10,079 shares for approximately $3.08 million at an average price of $305.15, reducing her direct ownership by 31.93% to 21,482 shares.
- CME Group reported quarterly revenue of $1.74 billion and EPS of $3.02, exceeding analyst estimates, while revenue increased 10.6% year over year.
- Analysts maintain a consensus rating of “Hold” with an average price target of $314.44; the company also pays a $1.30 quarterly dividend, equivalent to a 1.7% yield.
CME Group Inc. (NASDAQ:CME - Get Free Report) insider Julie Winkler sold 10,079 shares of the company's stock in a transaction that occurred on Monday, November 2nd. The stock was sold at an average price of $305.15, for a total transaction of $3,075,606.85. Following the completion of the sale, the insider directly owned 21,482 shares of the company's stock, valued at approximately $6,555,232.30. This represents a 31.93% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website.
CME Group Stock Performance
Shares of NASDAQ CME opened at $306.24 on Tuesday. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02. The firm has a market cap of $110.12 billion, a P/E ratio of 25.12, a PEG ratio of 3.59 and a beta of 0.24. The stock has a fifty day moving average price of $280.96 and a two-hundred day moving average price of $280.20. CME Group Inc. has a 1 year low of $218.31 and a 1 year high of $329.16.
CME Group (NASDAQ:CME - Get Free Report) last released its earnings results on Wednesday, October 21st. The financial services provider reported $3.02 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.99 by $0.03. CME Group had a return on equity of 16.23% and a net margin of 63.33%. The firm had revenue of $1.74 billion for the quarter, compared to analyst estimates of $1.71 billion. During the same period in the previous year, the company earned $2.68 earnings per share. CME Group's revenue was up 10.6% compared to the same quarter last year. Research analysts forecast that CME Group Inc. will post 12.34 EPS for the current fiscal year.
CME Group Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Friday, September 25th. Stockholders of record on Wednesday, September 9th were paid a dividend of $1.30 per share. The ex-dividend date of this dividend was Wednesday, September 9th. This represents a $5.20 annualized dividend and a dividend yield of 1.7%. CME Group's dividend payout ratio (DPR) is currently 42.66%.
Institutional Trading of CME Group
Hedge funds have recently bought and sold shares of the stock. Asset One Wealth Management LLC bought a new stake in shares of CME Group in the third quarter valued at about $445,000. International Assets Investment Management LLC grew its position in CME Group by 2.4% during the third quarter. International Assets Investment Management LLC now owns 2,509 shares of the financial services provider's stock worth $665,000 after buying an additional 60 shares in the last quarter. Heritage Family Offices LLP bought a new position in CME Group during the third quarter valued at about $192,000. Calamos Advisors LLC increased its stake in CME Group by 2.1% during the third quarter. Calamos Advisors LLC now owns 38,498 shares of the financial services provider's stock valued at $10,086,000 after acquiring an additional 778 shares during the period. Finally, Alta Advisers Ltd increased its stake in CME Group by 87.5% during the third quarter. Alta Advisers Ltd now owns 2,617 shares of the financial services provider's stock valued at $686,000 after acquiring an additional 1,221 shares during the period. 87.75% of the stock is owned by institutional investors.
Wall Street Analyst Weigh In
Several equities analysts have weighed in on CME shares. Wells Fargo & Company lifted their price objective on shares of CME Group from $315.00 to $333.00 and gave the stock an "overweight" rating in a research report on Thursday, October 22nd. Barclays lifted their price objective on CME Group from $281.00 to $321.00 and gave the company an "equal weight" rating in a research report on Thursday, October 22nd. Bank of America boosted their target price on shares of CME Group from $226.00 to $230.00 and gave the stock an "underperform" rating in a research report on Thursday, July 23rd. UBS Group increased their price objective on CME Group from $270.00 to $310.00 and gave the company a "neutral" rating in a report on Thursday, October 22nd. Finally, JPMorgan Chase & Co. upgraded shares of CME Group from an "underweight" rating to an "overweight" rating and set a $367.00 target price on the stock in a research note on Thursday, October 22nd. Ten research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and two have issued a Sell rating to the company's stock. According to data from MarketBeat.com, the stock presently has an average rating of "Hold" and a consensus price target of $314.44.
Check Out Our Latest Analysis on CME Group
CME Group Company Profile
(
Get Free Report)
CME Group Inc operates global derivatives marketplaces that provide trading, clearing and settlement services for futures and options contracts. Its products cover major asset classes, including interest rates, equity indexes, foreign currencies, agricultural commodities, energy and metals. The company also provides market data, benchmark information and related services used by financial institutions, corporations, producers, investors and other market participants.
CME Group's exchange portfolio includes CME, the Chicago Board of Trade, the New York Mercantile Exchange and COMEX.
Read More
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
